Health Frequency Inc
Silence the Noise. Heal Your Cells.
Developing non-invasive biophysical solutions to eliminate microvascular hypoxia and restore cellular longevity.
How We Help
Leadership
Problem Statement
You know how constant environmental electromagnetic noise can just wear you down? This 'ambient wave interference' structurally messes with your cellular membranes, directly impairing microvascular circulation and reducing mitochondrial efficiency. This leaves you with reduced oxygen delivery and unstable thermoregulation, and unfortunately, most standard longevity interventions completely miss this fundamental environmental bottleneck.
Core Technology
Patented biocompatible metal alloys (U.S. Patent No. 2013/0259736).
Key Differentiators
Patented core alloy formula (U.S. Patent No. 2013/0259736), first-mover advantage in ambient wave neutralization applied directly to microvascular homeostatic textiles, high barrier to entry due to deep-tech metallurgical composition and specialized integration process, and rigorous empirical thermographic and cellular research.
Clinical Focus
Microvascular circulation, mitochondrial efficiency, thermoregulation, cellular longevity, physiological homeostasis.
Target Customers
Health-conscious high-net-worth individuals, longevity enthusiasts, biohackers, preventive health practitioners, premium apparel and wellness brands, research institutes, longevity clinics, and bio-protection organizations.
Product Stage
Prototype
Company Info
- Business Model
- D2C, B2B Licensing, Institutional Partnerships
- Website
- healthfrequency.com
Technologies
Clinical & IP
Clinical Validation
Immediate restoration of microcirculation and thermal regulation demonstrated by thermographic imaging, showing measurable heat redistribution and increased peripheral vascular perfusion. Sustained stabilization of tissue temperature without active external heat sources. Built on Glen Rein's scientific foundation on ambient wave interference and mitochondrial response. Further clinical/empirical biomarker studies are underway.
IP Protection
Granted U.S. Patent No. 2013/0259736 for core alloy composition. Robust international patent strategy protecting core alloy composition and integration methods.
Only accessible to MedStartr community members.
Join nowWhat do you think of Health Frequency Inc?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.